rs3752755 |
chr2 |
240004245 |
0.00054 |
C |
T |
Coronary heart disease |
HDAC4 |
intron |
21966275
|
rs3791398 |
chr2 |
240025666 |
0.000018 |
G |
A |
Carotid intima media thickness |
HDAC4 |
intron |
19679847
|
rs3791399 |
chr2 |
240025761 |
0.0000037 |
G |
A |
Urinary metabolites |
HDAC4 |
intron |
21572414
|
rs747787 |
chr2 |
240032319 |
0.00048 |
G |
A |
Myocardial infarction |
HDAC4 |
intron |
21107343
|
rs3791426 |
chr2 |
240039401 |
0.000506 |
A |
G |
Salmonella-induced pyroptosis |
HDAC4 |
intron |
22837397
|
rs3791446 |
chr2 |
240045350 |
0.000347 |
T |
C |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
HDAC4 |
intron |
20877124
|
rs3791461 |
chr2 |
240051965 |
0.000378 |
G |
A |
Multiple complex diseases |
HDAC4 |
intron |
17554300
|
rs3791461 |
chr2 |
240051965 |
0.000014 |
G |
A |
Urinary metabolites |
HDAC4 |
intron |
21572414
|
rs12469994 |
chr2 |
240053966 |
0.000541 |
G |
A |
Alzheimer's disease |
HDAC4 |
intron |
24755620
|
rs2121980 |
chr2 |
240055553 |
0.000071 |
T |
C |
Dental caries |
HDAC4 |
intron |
21940522
|
rs2121980 |
chr2 |
240055553 |
0.0000346 |
T |
C |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
HDAC4 |
intron |
23233654
|
rs2121980 |
chr2 |
240055553 |
0.0000346 |
T |
C |
Methotrexate clearance (acute lymphoblastic leukemia) |
HDAC4 |
intron |
23233662
|
rs3791511 |
chr2 |
240080540 |
0.0000643 |
G |
A |
Melanoma |
HDAC4 |
intron |
21926416
|
rs7599555 |
chr2 |
240086580 |
0.000515 |
C |
T |
Multiple complex diseases |
HDAC4 |
intron |
17554300
|
rs1448430 |
chr2 |
240092739 |
0.000081 |
G |
A |
Bipolar disorder |
HDAC4 |
intron |
22925353
|
rs489806 |
chr2 |
240099456 |
0.000306 |
C |
A |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs3791549 |
chr2 |
240109024 |
0.0000417 |
G |
A |
Multiple complex diseases |
HDAC4 |
intron |
17554300
|
rs3828222 |
chr2 |
240109568 |
0.0000455 |
C |
T |
Multiple complex diseases |
HDAC4 |
intron |
17554300
|
rs3791556 |
chr2 |
240112972 |
0.000028 |
G |
A |
Diabetic retinopathy |
HDAC4 |
intron |
21441570
|
rs3791556 |
chr2 |
240112972 |
0.000008 |
G |
A |
Autism spectrum disorder,attention deficit-hyperactivity disorder,bipolar disorder,major depressive disorder,and schizophrenia (combined) |
HDAC4 |
intron |
23453885
|
rs753302 |
chr2 |
240114137 |
0.000704 |
A |
G |
Amyotrophic Lateral Sclerosis |
HDAC4 |
intron |
17827064
|
rs6735945 |
chr2 |
240115818 |
0.0000628 |
G |
C |
Cisplatin and carboplatin cytotoxicity,in blood cell lines |
HDAC4 |
intron |
21844884
|
rs496316 |
chr2 |
240155231 |
0.000018 |
T |
C |
Urinary metabolites |
HDAC4 |
intron |
21572414
|
rs12151485 |
chr2 |
240176736 |
0.000162 |
G |
A |
IgE levels |
HDAC4 |
intron |
17255346
|
rs7595357 |
chr2 |
240180336 |
0.0000129 |
C |
A |
IgE levels |
HDAC4 |
intron |
17255346
|
rs7595357 |
chr2 |
240180336 |
0.0000704 |
C |
A |
Weight |
HDAC4 |
intron |
pha003027
|
rs1403608 |
chr2 |
240181872 |
0.000586 |
G |
A |
Type 2 diabetes |
HDAC4 |
intron |
17463246
|
rs7587786 |
chr2 |
240186518 |
0.00000673 |
G |
A |
Body mass index |
HDAC4 |
intron |
19557197
|
rs6742576 |
chr2 |
240187632 |
0.00000656 |
G |
A |
Body mass index |
HDAC4 |
intron |
19557197
|
rs10208713 |
chr2 |
240188918 |
0.000494 |
C |
T |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs6745266 |
chr2 |
240193575 |
0.00000615 |
G |
A |
Body mass index |
HDAC4 |
intron |
19557197
|
rs6737742 |
chr2 |
240216021 |
0.0000858 |
G |
A |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs6737742 |
chr2 |
240216021 |
0.0000553 |
G |
A |
Response to acetaminophen (hepatotoxicity) |
HDAC4 |
intron |
21177773
|
rs908262 |
chr2 |
240217522 |
0.0000858 |
C |
A |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs908262 |
chr2 |
240217522 |
0.0000371 |
C |
A |
Response to acetaminophen (hepatotoxicity) |
HDAC4 |
intron |
21177773
|
rs925738 |
chr2 |
240241255 |
0.000476 |
C |
T |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs950225 |
chr2 |
240258244 |
0.00079 |
C |
T |
Myocardial infarction |
HDAC4 |
intron |
21107343
|
rs908265 |
chr2 |
240262287 |
0.0000927 |
T |
C |
Triglycerides |
HDAC4 |
intron |
pha002904
|
rs11686104 |
chr2 |
240286146 |
0.000103 |
G |
A |
Hemoglobin concentration |
HDAC4 |
intron |
20534544
|
rs11124194 |
chr2 |
240290494 |
0.0000522 |
C |
T |
Response to cytadine analogues (cytosine arabinoside) |
HDAC4 |
intron |
24483146
|
rs11124194 |
chr2 |
240290494 |
0.000662 |
C |
T |
Response to cytidine analogues (gemcitabine) |
HDAC4 |
intron |
24483146
|
rs2411843 |
chr2 |
240294969 |
0.0000547 |
A |
C |
Bladder cancer (smoking interaction) |
HDAC4 |
intron |
24662972
|